Odomzo (sonidegib)
pCPA File Number:
21480
Negotiation Status:
Negotiations were not pursued
Indication(s):
Basal Cell Carcinoma (BCC), locally advanced in adult patients with histologically confirmed laBCC that is not amenable to radiation therapy or curative surgery
Sponsor/Manufacturer:
Sun Pharma Canada Inc.
CDA-AMC Project Number:
PC0215-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: